Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7286
    -0.0002 (-0.03%)
     

  • CRUDE OIL

    79.24
    +0.25 (+0.32%)
     

  • Bitcoin CAD

    83,603.16
    -2,029.10 (-2.37%)
     

  • CMC Crypto 200

    1,299.79
    +5.12 (+0.40%)
     

  • GOLD FUTURES

    2,315.90
    -6.40 (-0.28%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,163.25
    -23.25 (-0.13%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • CAD/EUR

    0.6776
    0.0000 (0.00%)
     

SORRENTO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Sorrento Therapeutics, Inc. To Contact The Firm

Newsfile Corp.
·1 min read

New York, New York--(Newsfile Corp. - May 23, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sorrento Therapeutics, Inc. (NASDAQ: SRNE) ("Sorrento" or the "Company").



Faruqi & Faruqi logo

If you invested in Sorrento stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/SRNE. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

ADVERTISEMENT

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/56436